|
Volumn 11, Issue 2, 1997, Pages 268-269
|
Saquinavir interaction with midazolam: Pharmacokinetic considerations when prescribing protease inhibitors for patients with HIV disease [13]
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZITHROMYCIN;
CLARITHROMYCIN;
COTRIMOXAZOLE;
CYTOCHROME P450;
ERYTHROMYCIN;
FLUCONAZOLE;
FLUMAZENIL;
INDINAVIR;
ITRACONAZOLE;
KETOCONAZOLE;
LACTATE DEHYDROGENASE;
LAMIVUDINE;
MIDAZOLAM;
PROTEINASE INHIBITOR;
RITONAVIR;
SAQUINAVIR;
ZALCITABINE;
ZIDOVUDINE;
ADULT;
ANTIVIRAL ACTIVITY;
CASE REPORT;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG METABOLISM;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRAVENOUS DRUG ADMINISTRATION;
LETTER;
MALE;
PRIORITY JOURNAL;
SEDATION;
ADULT;
ANTI-HIV AGENTS;
CYTOCHROME P-450 ENZYME SYSTEM;
DRUG INTERACTIONS;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HUMANS;
HYPNOTICS AND SEDATIVES;
LAMIVUDINE;
LIVER;
MALE;
MIDAZOLAM;
SAQUINAVIR;
TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;
ZIDOVUDINE;
|
EID: 0031032476
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (30)
|
References (7)
|